By leveraging large-scale multi-omics and single-cell RNA sequencing (scRNA-seq), we characterize the tumor microenvironment of HR<sup>+</sup>/HER2<sup>-</sup> breast cancer, revealing that an abundance of activated natural killer (NK) cells correlates with favorable anti-PD-(L)1 responses. The gene discussed is ERBB2; the disease is breast carcinoma.